申请人:——
公开号:US20030008829A1
公开(公告)日:2003-01-09
The present invention relates to a series of peptidyl heterocyclic ketones which are inflammatory cell serine protease inhibitors and their compositions and methods for the prevention and treatment of a variety of immunomediated inflammatory disorders. More particularly, these compounds are potent and selective inhibitors of tryptase and are therefore effective for the prevention and treatment of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis.
本发明涉及一系列肽杂环酮,它们是炎症细胞丝氨酸蛋白酶抑制剂及其组合物和用于预防和治疗各种免疫介导的炎症性疾病的方法。更具体地说,这些化合物是强效且选择性的组胺酶抑制剂,因此对于预防和治疗与呼吸道相关的炎症性疾病,如哮喘和过敏性鼻炎,非常有效。